DelveInsight's Inflammatory Bowel disease market Report provides comprehensive insights into the epidemiology and market dynamics across the 7MM. LAS VEGAS , NV, UNITED STATES, January 30, 2025 ...

Mayo Clinic's organoids, microscopic versions of organs that function like the real ones, have been used by doctors to study ...

A Waterlooville father who lost his wife to bowel cancer after living with colitis for more than half her life, has welcomed ...

Doctors believe new test could lead to earlier diagnoses and more effective treatment for thousands of patients ...

Celltrion, a leading Korean biotechnology firm, has successfully developed Zymfentra, a subcutaneous version of the company’s ...

Scientists have developed a groundbreaking test that may predict bowel cancer risk with up to 90% accuracy. The research, ...

Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in ...

Having multiple sclerosis (MS) was associated with higher rates of mental illness during the peripartum period than not ...

ROCHESTER, Minnesota — Mayo Clinic researchers have developed  organoid models  to study  uveal melanoma , one of the most common types of eye cancer ...

Teva Pharmaceutical is a victim of its own success, Chief Executive Richard Francis said Wednesday as Teva stock plummeted on ...

There are a number of genomics startups that have sprouted up to strengthen their sequencing technologies to aid in disease prevention and treatment.

Several ASX-listed companies are undertaking phase III clinical trials, the critical final stage before potential regulatory ...